TEICOPLANIN'S ADMINISTRATION IN ANTIBACTERIAL THERAPY OF PATIENTS WITH HIGH RISK OF DEVELOPMENT OF LIFE-THREATENING INFECTIONS
21 July 2015
Problems of modern antibacterial therapy explain the increased interest to glycopeptide antibiotics, active against most resistant Gram-positive cocci: methicillin- resistant staphilococci, penicillin-resistant pneumococci and enterococci.